MedicarePartD.guide

A non-government resource built from CMS public data

JAK inhibitors and other oral immunology drugs on every 2026 Guam Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in Guam cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
JAK inhibitors and other oral immunology drugs by 2026 Guam Part D plan
DrugAARP Medicare Rx Preferred from UHC$0.00/moS5820-035
RinvoqupadacitinibTier 5PA25%QL 360/30d
XeljanztofacitinibNot covered
OlumiantbaricitinibNot covered
OtezlaapremilastTier 5PA25%QL 60/30d
SotyktudeucravacitinibTier 5PA25%QL 30/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.